RE:Near term catalystsWhy would that news move the stock? The clinical data has already been great, hasn't it? I could easily be wrong, wouldn't be the first time, but until they prove they aren't going to struggle to stay funded & until they get some new official credibility (FDA) then will the stock do anything? The recent NR flurry would have sent most penny stocks to the moon on hype, IMO. Their audience seems to be in a state of low trust or disbelief or the impression of the complete lack of de-risking? Will they run out of money and go belly up before anything truly good happens? Or will they fail to get BTD? Will any of their preclinical research translate to humans and when (see funding risks)? It's like a circle of risk doom right now, it seems.
Who knows, maybe some here are correct in that closing a much bigger PP will move the stock because at that point all the recent news can be used more readily as a future potential value catalyst for the stock price?